You are here

  • Home
  • Archive
  • Volume 11, Issue 7
  • A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

Article metrics

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Protocol
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

 

Online download statistics by month:

Online download statistics by month: July 2021 to April 2024

AbstractFullPdf
Jul 2021472477130
Aug 2021291289198
Sep 2021147142107
Oct 202116214671
Nov 202116214977
Dec 202111911747
Jan 2022787239
Feb 2022666741
Mar 2022989450
Apr 2022787844
May 2022788155
Jun 2022575938
Jul 2022644928
Aug 2022454331
Sep 2022605942
Oct 2022585432
Nov 2022666326
Dec 2022595625
Jan 2023514736
Feb 2023565338
Mar 2023433723
Apr 2023352738
May 2023454242
Jun 2023413534
Jul 2023262628
Aug 2023373522
Sep 2023383539
Oct 2023505226
Nov 2023727128
Dec 2023666554
Jan 2024635835
Feb 2024504327
Mar 2024686461
Apr 2024221937
Total292328041649